- Home
- XBP vs GDTC Comparison
XBP vs GDTC Comparison
Compare XBP & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- GDTC
- Stock Information
- Founded
- XBP N/A
- GDTC 2018
- Country
- XBP United Kingdom
- GDTC Singapore
- Employees
- XBP N/A
- GDTC N/A
- Industry
- XBP Business Services
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- XBP Consumer Discretionary
- GDTC Health Care
- Exchange
- XBP Nasdaq
- GDTC Nasdaq
- Market Cap
- XBP 32.2M
- GDTC 28.0M
- IPO Year
- XBP N/A
- GDTC 2023
- Fundamental
- Price
- XBP $0.92
- GDTC $2.21
- Analyst Decision
- XBP
- GDTC Buy
- Analyst Count
- XBP 0
- GDTC 1
- Target Price
- XBP N/A
- GDTC $5.00
- AVG Volume (30 Days)
- XBP 76.5K
- GDTC 6.5K
- Earning Date
- XBP 08-11-2025
- GDTC 01-01-0001
- Dividend Yield
- XBP N/A
- GDTC N/A
- EPS Growth
- XBP N/A
- GDTC N/A
- EPS
- XBP N/A
- GDTC N/A
- Revenue
- XBP $142,332,000.00
- GDTC $368,838.00
- Revenue This Year
- XBP N/A
- GDTC $5.37
- Revenue Next Year
- XBP N/A
- GDTC N/A
- P/E Ratio
- XBP N/A
- GDTC N/A
- Revenue Growth
- XBP N/A
- GDTC N/A
- 52 Week Low
- XBP $0.79
- GDTC $1.20
- 52 Week High
- XBP $1.89
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- XBP 41.85
- GDTC 49.36
- Support Level
- XBP $0.81
- GDTC $2.09
- Resistance Level
- XBP $0.93
- GDTC $2.35
- Average True Range (ATR)
- XBP 0.08
- GDTC 0.10
- MACD
- XBP -0.00
- GDTC 0.00
- Stochastic Oscillator
- XBP 30.72
- GDTC 50.00
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology, focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.